TIGEN
Live / Registered — Registered (as of 22 Mar 2022)
What this means for you
Registered since 22 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79304640
- Registration number
- 6674502
- Mark type
- Stylized text
- Filed
- 13 Nov 2020
- Published for opposition
- 04 Jan 2022
- Registered
- 22 Mar 2022
- Attorney of record
- Stacey Halpern
Goods and services
- Class 001 — Chemicals: Chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in industry and science; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in the development being the manufacture, and manufacture of reagents for industrial or scientific use; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides or proteins, for use of laboratories, diagnostics and analyses for industrial or scientific use; chemical, biochemical, biological and biotechnological substances, namely, polypeptides and proteins, for use in the manufacture of pharmaceuticals
- Class 005 — Pharmaceuticals: Pharmaceutical products and medical preparations, namely, gene-modified and non-gene-modified cellular therapies for the treatment of localized and systemic malignant hematological and oncological diseases, genetic diseases, autoimmune diseases and infectious diseases
- Class 010 — Medical apparatus: Medical instruments, equipment and apparatus, namely, instruments, equipment and apparatus for cell and cell material collection, thawing, washing, selection, expansion, modification, harvesting, final formulation, freezing, storage and infusion into a patient in the fields of genetic diseases, autoimmune diseases, infectious diseases, localized and systemic malignant hematological and oncological diseases and other cell and cell-material based diseases and conditions
- Class 042 — Scientific and technological services: Scientific research, technological development of new products for third parties; medical research; scientific and industrial research in biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific services, namely, development of medicines, active substances and vaccines; scientific services, namely, development of food supplement; design and development of computer hardware and software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; upgrading, maintenance and rental of computer software; updating, maintenance and rental of computer software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; software as a service (SaaS) services featuring software for controlling end-to-end process development, manufacturing, quality, and supply chain steps and featuring artificial intelligence search engine software to be used in medical and scientific research and in the development of new products in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; chemical and biological laboratory services
- Class 044 — Medical, beauty and agricultural services: Medical services; pharmacy advice services, namely, pharmaceutical consultation; medical clinic services provided by medical laboratories for diagnostic purposes; preparation and dispensing of medication; preparation of prescriptions by pharmacists
Owner
- Tigen Pharma SA, CH
- Tigen Pharma SA, CH
- Tigen Pharma SA, CH
Prosecution history
- 13 Jun 2025 — LIMITATION OF GOODS RECEIVED FROM IB
- 06 Jun 2025 — LIMITATION OF GOODS RECEIVED FROM IB
- 31 Dec 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 Sept 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 15 Aug 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 15 Aug 2022 — FINAL DISPOSITION PROCESSED
- 22 Jun 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 04 Jan 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jan 2022 — PUBLISHED FOR OPPOSITION
- 01 Jan 2022 — NOTIFICATION PROCESSED BY IB
- 15 Dec 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 15 Dec 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 15 Dec 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Nov 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER